BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7020177)

  • 1. Prevention of graft-versus-host reaction in mice by picogram quantities of highly purified spleen-derived immunosuppressive peptide.
    Millerioux-Di Giusto L; Kiger N; Duchange N; Lenfant M
    Transplantation; 1981 Feb; 31(2):147-9. PubMed ID: 7020177
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suppression of the graft vs host reaction after the inoculation of lymphocytes into the liver of F1 hybrid mice].
    Divanian Kh; Stoianov S; Softova E
    Eksp Med Morfol; 1983; 22(3):30-3. PubMed ID: 6671447
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells.
    Bennett M
    J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased graft-versus-host reaction and T cell cytolytic potential of beige mice.
    Halle-Pannenko O; Bruley-Rosset M
    Transplantation; 1985 Jan; 39(1):85-7. PubMed ID: 3880970
    [No Abstract]   [Full Text] [Related]  

  • 5. Veto cells are not responsible for alloimmunization-induced abrogation of lethal graft-versus-host reaction.
    Halle-Pannenko O; Bruley-Rosset M; Pritchard LL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):549-50. PubMed ID: 2978923
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of graft-versus-host mortality in mice by preincubation of the graft with highly purified spleen-derived immunosuppressive peptides.
    Kiger N; Lenfant M
    Transplantation; 1983 Sep; 36(3):243-6. PubMed ID: 6351365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of acute graft-versus-host disease by treatment with a novel immunosuppressant. Cholera toxin B subunit.
    Yankelevich B; Brown E; Mazumder A
    J Immunol; 1995 Apr; 154(7):3611-7. PubMed ID: 7897240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of graft versus host reactivity by a single host-specific blood transfusion to prospective donors of hemopoietic cells.
    Knulst AC; Bril-Bazuin C; Ruizeveld de Winter JA; Benner R
    Transplant Proc; 1990 Aug; 22(4):1975-6. PubMed ID: 2389502
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction.
    Gerber NL; Hardin JA; Chused TM; Steinberg AD
    J Immunol; 1974 Nov; 113(5):1618-25. PubMed ID: 4153571
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the repertoire of T-cell lines and clones specific for minor histocompatibility antigens derived from immunized mice and from mice developing a graft-versus-host reaction.
    Bruley-Rosset M; Miconnet I; Roger T; Seman M; Halle-Pannenko O
    Transplant Proc; 1993 Feb; 25(1 Pt 1):94-5. PubMed ID: 8438503
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
    Gallagher MT; Richie ER; Heim LR; Judd KP; Trentin JJ
    Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LF 08-0299 protects murine recipients of minor antigen disparate donor bone marrow from lethal graft-versus-host disease.
    Bruley-Rosset M; Churaqui E; Annat J; Dutartre P
    Transplant Proc; 1996 Dec; 28(6):3114-6. PubMed ID: 8962208
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral tolerance specific for host minor histocompatibility antigens in acute GVHR-protected mice is associated with functional deletion of CD4+ but not CD8+ T cells and an active suppressive mechanism.
    Miconnet I; Bruley-Rosset M; Halle-Pannenko O
    Transplant Proc; 1993 Feb; 25(1 Pt 1):327-8. PubMed ID: 8438320
    [No Abstract]   [Full Text] [Related]  

  • 17. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
    Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
    J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of hemopoietic regeneration on the course of a systemic "graft vs host" reaction].
    Meshkova RIa; Konoshenko GB; Kurchizhkina LI
    Biull Eksp Biol Med; 1980 Aug; 90(8):218-9. PubMed ID: 7407399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of graft-vs-host reaction by a spleen extract.
    Garcia-Giralt E; Morales VH; Lasalvia E; Mahte G
    J Immunol; 1972 Oct; 109(4):878-80. PubMed ID: 4403776
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of graft-versus-host reaction in rats by cell-free extract from heterologous liver.
    Skowron-Cendrzak A; Plonkowa I; Rybczyńska Z; Kowalczyk K; Turowski G
    Arch Immunol Ther Exp (Warsz); 1974; 22(4):457-66. PubMed ID: 4153987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.